Eaton Vance Management Fibrogen Inc Transaction History
Eaton Vance Management
- $67.5 Billion
- Q3 2022
A detailed history of Eaton Vance Management transactions in Fibrogen Inc stock. As of the latest transaction made, Eaton Vance Management holds 94,478 shares of FGEN stock, worth $873,921. This represents 0.0% of its overall portfolio holdings.
Number of Shares
94,478
Previous 94,478
-0.0%
Holding current value
$873,921
Previous $998,000
23.15%
% of portfolio
0.0%
Previous 0.0%
Shares
7 transactions
Others Institutions Holding FGEN
# of Institutions
10Shares Held
4MCall Options Held
35KPut Options Held
0-
Black Rock Inc. New York, NY2.41MShares$22.3 Million0.0% of portfolio
-
Pictet Asset Management Sa Geneva 73, V81.37MShares$12.7 Million0.0% of portfolio
-
Intercontinental Wealth Advisors, LLC95.7KShares$884,7620.06% of portfolio
-
Connective Capital Management, LLC Palo Alto, CA15KShares$138,7500.07% of portfolio
-
Cibc Private Wealth Group, LLC7.18KShares$66,3780.0% of portfolio
About FIBROGEN INC
- Ticker FGEN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 93,741,200
- Market Cap $867M
- Description
- FibroGen, Inc., a biopharmaceutical company, discovers, develops, and commercializes therapeutics to treat serious unmet medical needs. The company is developing Roxadustat, an oral small molecule inhibitor of hypoxia inducible factor prolyl hydroxylases, which has completed Phase III clinical development for the treatment of anemia in chronic k...